BioCentury
ARTICLE | Company News

Elan, Solstice deal

July 12, 2004 7:00 AM UTC

ELN sold the worldwide rights for Myobloc/ Neurobloc to Solstice Neurosciences. Myobloc is an injectable solution of botulinum toxin Type B to reduce the severity of abnormal head position and neck p...